Xun Meng, Ph.D. – Chief Executive Officer Dr. Meng is a serial entrepreneur and has successfully launched 4 biotechnology companies in a 12-year span, among which Epitome Biosystems was acquired by Millipore.

2015年6月16日 · Xun has created novel technologies for genomics (optical mapping, NYU) and proteomics (PET antibody array technology, Epitome Biosystems). At Abmart, he has lead the invention of antibody library technologies for proteins (SEAL) and proteomes (MabArray).

2024年8月20日 · Dr. Xun Meng, Chief Executive Officer of Multitude, stated: “We are delighted to collaborate globally with Adcendo. The successful cooperation demonstrates that the T1000-exatecan linker-payload platform has played a significant role …

Experience: eBay · Education: University of Florida · Location: San Jose · 500+ connections on LinkedIn. View Xun Meng’s profile on LinkedIn, a professional community of 1 billion members.

Xun Meng's 5 research works with 345 citations and 181 reads, including: Carbon-coated defect-rich MnFe2O4/MnO heterojunction for high-performance microwave absorption

XUN MENG INTERNATIONAL LIMITED information, includes incorporation date, status, type, directors, address, contacts & more.

It takes a dark turn as his rebellion is crushed, and loss becomes a catalyst. The story not only tells about a revolution but also delves into the emotional complexities of the characters, exploring themes of leadership, sacrifice, and the haunting question of what true victory means in a world torn apart by inequality.

We investigate the radiation effects of 1907 MeV Ta ions on the static and dynamic characteristics of 850 nm high-speed vertical cavity surface emitting lasers (VCSELs). The threshold current and...

View Xun Meng’s profile on LinkedIn, a professional community of 1 billion members.

I’m Xun, a user experience designer. I enjoy breaking up problems that challenge how I feel, think, and create.